Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,397.63
-0.0%
-3.33
Arrow-Thin-Down
DJI
49,573.56
-0.4%
-187.00
Arrow-Thin-Down
NASDAQ
26,126.84
+0.1%
+38.64
Arrow-Thin-Down
Bitcoin
$79,570.00
-1.1%
-$889.69
Arrow-Thin-Down
AAPL
$295.43
+0.2%
+$0.63
Arrow-Thin-Down
AMZN
$265.33
-0.2%
-$0.49
Arrow-Thin-Down
GOOG
$389.47
+1.5%
+$5.65
Arrow-Thin-Down
META
$606.60
+0.6%
+$3.60
Arrow-Thin-Down
MSFT
$404.08
-0.9%
-$3.69
Arrow-Thin-Down
NVDA
$224.58
+1.7%
+$3.80
Arrow-Thin-Down
TSLA
$439.72
+1.4%
+$6.27
Most Active StocksDaily Stock GainersDaily Stock Losers
Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

(NASDAQ) CPRX

Current Price$31.16
Market Cap$3.81B
Since IPO (2006)+411%
5 Year+525%
1 Year+31%
1 Month+25%

Catalyst Pharmaceuticals Financials at a Glance

Market Cap

$3.81B

Revenue (TTM)

$596.96M

Net Income (TTM)

$221.32M

EPS (TTM)

$1.74

P/E Ratio

17.90

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$31.16

Volume

11,065

Open

$31.17

Previous Close

$31.14

Daily Range

$31.16 - $31.19

52-Week Range

$19.05 - $32.56

CPRX News

SellAlert-Blue.png

Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move?

Sara AppinoDec 31, 2025
Person about to receive a vaccine shot

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

Eric VolkmanApr 3, 2025
investing screen analysis investor growth stocks

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today

James BrumleyFeb 27, 2025
growth stock

2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

George Budwell, PhDMay 15, 2024
two investors consider a laptop

3 Biotech Stocks You Can Buy and Hold for the Next Decade

Alex CarchidiJan 15, 2024
scientists talking about antiviral drug in laboratory

Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024

Alex CarchidiJan 14, 2024
Physicians in a hospital operating room

2 Robinhood Stocks With Market-Beating Potential

James HalleyOct 14, 2023
frustrated investor at computers

Down 19% in 1 Day, Is Catalyst Pharmaceuticals a Smart Contrarian Buy?

Alex CarchidiMay 22, 2023
Page 1

CPRX: Motley Fool Moneyball Superscore

71

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Catalyst Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

182

CEO

Richard John Daly, MBA

Website

www.catalystpharma.com

Headquarters

Coral Gables, FL 33134, US

CPRX Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

45%

Net Income Margin

37%

Return on Equity

24%

Return on Capital

26%

Return on Assets

19%

Earnings Yield

5.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.81B

Shares Outstanding

122.35M

Volume

11.06K

Avg. Volume

1.82M

Financials (TTM)

Gross Profit

$501.74M

Operating Income

$257.78M

EBITDA

$321.01M

Operating Cash Flow

$208.67M

Capital Expenditure

$58.00K

Free Cash Flow

$208.61M

Cash & ST Invst.

$709.17M

Total Debt

$2.79M

Catalyst Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$149.39M

+5.6%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$3.81B

N/A

Market Cap/Employee

$21.05M

N/A

Employees

181

N/A

Net Income

$63.73M

+12.3%

EBITDA

$73.23M

+0.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$753.62M

+30.5%

Accounts Receivable

$130.83M

+81.1%

Inventory

$34.93M

+76.6%

Long Term Debt

$2.23M

-16.6%

Short Term Debt

$0.00

-100.0%

Return on Assets

19.29%

N/A

Return on Invested Capital

26.36%

N/A

Free Cash Flow

$59.56M

-0.8%

Operating Cash Flow

$59.59M

-0.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BEAMBeam Therapeutics Inc.
$31.62+0.13%
KNSAKiniksa Pharmaceuticals, Ltd.
$59.63+0.25%
IDYAIDEAYA Biosciences, Inc.
$28.47+1.24%
APLSApellis Pharmaceuticals, Inc.
$41.05-0.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
EOSEEos Energy Enterprises
$8.85+0.09%
VNETVnet Group
$11.77+0.30%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.99+0.00%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.33+0.00%

Questions About CPRX

What is the current price of Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals is trading at $31.17 per share.

What is the 52-week range for Catalyst Pharmaceuticals?

Over the past 52 weeks, Catalyst Pharmaceuticals has traded between $19.05 and $32.56.

How much debt does Catalyst Pharmaceuticals have?

As of the most recent reporting period, Catalyst Pharmaceuticals reported total debt of $2.68M.

How much cash does Catalyst Pharmaceuticals have on hand?

Catalyst Pharmaceuticals reported $755.86M in cash and cash equivalents in its most recent financial results.

What is Catalyst Pharmaceuticals’s dividend yield?

Catalyst Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services